Eligi
Med
Ensayos clinicos
Suscripcion
Sobre EligiMed
Ensayos Clinicos de Gastroenterologia | EligiMed
Ensayos clinicos
604 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
INTERVENTIONAL
Inicio: 27 de feb de 2018
ID: NCT03283085
Completado
ClinicalTrials.gov
Is the Placental Transfusion Volume Influenced by the Position of the New Born at Birth?
INTERVENTIONAL
Inicio: 1 de ago de 2011
ID: NCT01497353
Completado
ClinicalTrials.gov
Interactive Mobile Health Intervention to Support Patients With Active Tuberculosis
INTERVENTIONAL
Inicio: 9 de abr de 2019
ID: NCT03544476
Terminado
Fase 3
ClinicalTrials.gov
A 52-week, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis
INTERVENTIONAL
Inicio: 1 de feb de 2018
ID: NCT03383146
Completado
Fase 3
ClinicalTrials.gov
A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate Efficacy and Safety of Tiotropium Inhalation Solution Delivered Via Respimat® Inhaler (2.5 mcg and 5 mcg Once Daily) Over 12 Weeks as add-on Controller Therapy on Top of Usual Care in Adolescents (12 to 17 Years Old) With Severe Persistent Asthma
INTERVENTIONAL
Inicio: 1 de ene de 2011
ID: NCT01277523
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
INTERVENTIONAL
Inicio: 4 de abr de 2018
ID: NCT03290781
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2, Multi-center, Randomized, Double-blind, Placebo-controlled Parallel-group Study to Evaluate the Efficacy and Safety of Dupilumab Therapy in Patients With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype
INTERVENTIONAL
Inicio: 12 de ene de 2023
ID: NCT05731128
Completado
ClinicalTrials.gov
REFINE: Regorafenib Observational Study in Hepatocellular Carcinoma
OBSERVATIONAL
Inicio: 13 de sept de 2017
ID: NCT03289273
Completado
Fase 3
ClinicalTrials.gov
Satavaptan Cirrhotic Ascites Treatment Study: a Double-blind, Randomised, Parallel-group Comparison of Treatment With Satavaptan at 5 to 10 mg Daily Versus Placebo on Top of Conventional Treatment in Patients With Ascites Due to Cirrhosis of the Liver
INTERVENTIONAL
Inicio: 1 de jul de 2006
ID: NCT00358878
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Subcutaneous Amlitelimab in Adult Patients With Nonresponsive Celiac Disease as an Adjunct to a Gluten-free Diet
INTERVENTIONAL
Inicio: 29 de ago de 2024
ID: NCT06557772
Activo, no recluta
Fase 2
ClinicalTrials.gov
A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers
INTERVENTIONAL
Inicio: 1 de abr de 2025
ID: NCT06864169
Completado
Fase 3
ClinicalTrials.gov
A 24 Month, Multicenter, Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00622869
Completado
Fase 2
ClinicalTrials.gov
A Randomized Discontinuation Study of Brivanib Alaninate (BMS-582664) Versus Placebo in Subjects With Advanced Tumors
INTERVENTIONAL
Inicio: 1 de jun de 2008
ID: NCT00633789
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease
INTERVENTIONAL
Inicio: 17 de mar de 2025
ID: NCT06819878
Reclutando
ClinicalTrials.gov
Assessing the Usefulness of Functional Electrical Stimulation Program on Tibial Nerve for Rehabilitation of Chronic Stroke Patients
INTERVENTIONAL
Inicio: 21 de mar de 2022
ID: NCT05240716
Terminado
Fase 2
ClinicalTrials.gov
NASH EXploratory Single and COmbination Treatment (NEXSCOT): An Open Label, Multicenter, Platform Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of Various Single and Combination Treatments in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) Who Manifest a Non-alcoholic Steatohepatitis (NASH)-Like Biomarker Phenotype
INTERVENTIONAL
Inicio: 4 de jun de 2020
ID: NCT04147195
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIb Multicenter, 52 Week Treatment, Randomized, Blinded, Double Dummy, Parallel Group Efficacy Study Comparing the Effect of Inhaled Indacaterol 150 µg o.d. vs Inhaled Tiotropium 18 µg o.d. on Lung Function, Rate of Exacerbations and Related Outcomes in Patients With COPD
INTERVENTIONAL
Inicio: 1 de mar de 2009
ID: NCT00845728
Completado
Fase 3
ClinicalTrials.gov
A 26-week Treatment, Multicenter, Randomized, Double Blind, Double Dummy, Placebo-controlled, Adaptive, Seamless, Parallel-group Study to Assess the Efficacy, Safety and Tolerability of Two Doses of Indacaterol (Selected From 75, 150, 300 & 600 µg o.d.) in Patients With Chronic Obstructive Pulmonary Disease Using Blinded Formoterol (12 µg b.i.d.) and Open Label Tiotropium (18 µg o.d.) as Active Controls
INTERVENTIONAL
Inicio: 1 de abr de 2007
ID: NCT00463567
Completado
ClinicalTrials.gov
Indicators of Sub-Optimal Response to Anti-Tumor Necrosis Factor (TNF) Therapy in Patients With Crohn's Disease (CD) and Ulcerative Colitis (UC): A Retrospective Chart Review in the Emerging Market (EM) Region (EXPLORE)
OBSERVATIONAL
Inicio: 28 de mar de 2017
ID: NCT03090139
Completado
Fase 2
ClinicalTrials.gov
A Phase 1b/2, Multicenter, Open-label Basket Study Evaluating the Safety and Efficacy of Bemarituzumab Monotherapy in Solid Tumors With FGFR2b Overexpression (FORTITUDE-301)
INTERVENTIONAL
Inicio: 23 de sept de 2022
ID: NCT05325866
Anterior
1
...
28
29
30
31
Siguiente
Filtros